Heteroaryl β-tetralin ureas as novel antagonists of human TRPV1

被引:23
|
作者
Jetter, Michele C.
Youngman, Mark A.
McNally, James J.
McDonnell, Mark E.
Zhang, Sui-Po
Dubin, Adrienne E.
Nasser, Nadia
Codd, Ellen E.
Flores, Christopher M.
Dax, Scott L.
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Spring House, PA 19477 USA
[2] Johnson & Johnson Pharmaceut Res & Dev, San Diego, CA 92121 USA
关键词
TRPV1; antagonists; tetralin ureas;
D O I
10.1016/j.bmcl.2007.09.036
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report on a series of alpha-substituted-beta-tetralin-derived and related phenethyl-based isoquinolinyl and hydroxynaphthyl ureas as potent antagonists of the human TRPV1 receptor. The synthesis and Structure-activity relationships (SAR) of the series are described. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6160 / 6163
页数:4
相关论文
共 50 条
  • [41] The first human lacking functional TRPV1 channel: Implications on TRPV1 functions in nociception
    Katz, Ben
    Zaguri, Rachel
    Edvardson, Simon
    Elpeleg, Orly
    Lev, Shaya
    Maayan, Chana
    Davidson, Elyad
    Peters, Maximilian
    Berger, Esther
    Binshtok, Alexander
    Minke, Baruch
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2019, 48 : S58 - S58
  • [42] Design, synthesis, and evaluation of benzamide derivatives as TRPV1 antagonists
    Kuramochi, Takahiro
    Yonezawa, Koichi
    Asai, Norio
    Ikegai, Kazuhiro
    Miyamoto, Satoshi
    Shirakami, Shohei
    Akamatsu, Seijiro
    Kiso, Tetsuo
    Kohara, Atsuyuki
    Tsuji, Noriko
    Tsukamoto, Mina
    Ooe, Tomoya
    Okada, Minoru
    Sakamoto, Shuichi
    Watanabe, Toshihiro
    Ohta, Mitsuaki
    Tsukamoto, Shinichi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [43] Convergent Asymmetric Synthesis of Two Complex TRPV1 Antagonists
    Butcher, Kenneth J.
    Denton, Steven M.
    Field, Stuart E.
    Gillmore, Adam T.
    Harbottle, Gareth W.
    Howard, Roger M.
    Laity, Daniel A.
    Ngono, Christian J.
    Pibworth, Benjamin A.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (05) : 1192 - 1200
  • [44] Discovery of indane propanamides as potent and selective TRPV1 antagonists
    Ahn, Songyeon
    Kim, Yong Soo
    Kim, Myeong Seup
    Ann, Jihyae
    Ha, Heejin
    Yoo, Young Dong
    Kim, Young Ho
    Blumberg, Peter M.
    Frank-Foltyn, Robert
    Bahrenberg, Gregor
    Stockhausen, Hannelore
    Christoph, Thomas
    Lee, Jeewoo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (03)
  • [45] Differences in the effects of TRPV1 antagonists on energy metabolism in mice
    Hai, Jun
    Kawabata, Fuminori
    Kawabata, Yuko
    Liang, Ruojun
    Nishimura, Shotaro
    Tabata, Shoji
    BIOMEDICAL RESEARCH-TOKYO, 2018, 39 (06): : 279 - 286
  • [46] Spiro-piperidine azetidinones as potent TRPV1 antagonists
    Xiao, Dong
    Palani, Anandan
    Aslanian, Robert
    McKittrick, Brian A.
    McPhail, Andrew T.
    Correll, Craig C.
    Phelps, P. Tara
    Anthes, John C.
    Rindgen, Diane
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 783 - 787
  • [47] Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists
    Stec, Markian M.
    Bo, Yunxin
    Chakrabarti, Partha P.
    Liao, Lillian
    Ncube, Mqhele
    Tamayo, Nuria
    Tamir, Rami
    Gavva, Narender R.
    Treanor, James J. S.
    Norman, Mark H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) : 5118 - 5122
  • [48] TRP channel antagonists for pain - opportunities beyond TRPV1
    Bevan, Stuart
    Andersson, David A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (07) : 655 - 663
  • [49] TRPV1 AND TRPV4 ANTAGONISTS HAVE A SYNERGISTIC EFFECT DURING CYSTITIS
    Charrua, A.
    Cruz, C.
    Boudes, M.
    De Ridder, D.
    Cruz, F.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (06) : 742 - 743
  • [50] Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management
    Zhu, Kun
    Wang, Lin
    Liao, TingTing
    Li, Wen
    Zhou, Jing
    You, Yaodong
    Shi, Jianyou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261